ReviewBlood cancer discovery2024
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy.
Mohamed Abou-El-EneinPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it
ReviewBlood cancer discovery2024
Mohamed Abou-El-EneinPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.